Mary Haas

Company: Regeneron Pharmaceuticals

Job title: Associate Director - Cardiometabolic Metabolic and Skeletal Disease Genetics

Seminars:

2:30 PM Panel Discussion: From Discovery to Clinical: Integrating Genetics into Nephrology to Boost Early Detection & Uncover Novel Targets 2:30 pm

Exploring the increasing recognition of genetic etiologies in kidney disease and the need for strong genetic testing in nephrology practice Discussing how nephrologists can effectively identity patients who would benefit from genetic evaluation and understand appropriate timing and indications for testing Delving into the core components of genetic counselling to improve understanding of the support…Read more

day: Conference Day 2

3:00 PM Insights into Kidney Disease from Whole-Exome Sequencing at Scale 3:00 pm

Leveraging genetic and -omic data from natural history studies across diverse rare kidney diseases to create models that predict mechanistic markers of patient response Identifying correlations between patient gene profiles and biomarkers that can predict their likelihood of response to specific therapies Utilizing genetic and -omic signatures to develop targeted patient selection strategies for more…Read more

day: Conference Day 2